Arnold Library

Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk.

Phipps, Amanda I and Buist, Diana S M and Malone, Kathleen E and Barlow, William E and Porter, Peggy L and Kerlikowske, Karla and Li, Christopher I (2010) Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. Breast cancer research and treatment. ISSN 1573-7217 (In Press)

[thumbnail of Complete manuscript] Text (Complete manuscript)
PhippsABrCancResTrtmnt_010611.pdf
Restricted to Repository staff only
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (147kB)
Article URL: http://www.springerlink.com/content/b3538117x50841...

Abstract

Triple-negative breast cancer accounts for less than 20% of breast cancers overall, but is the predominant subtype among carriers of mutations in BRCA1. However, few studies have assessed the association between breast cancer family history and risk of triple-negative breast cancer. We examined the relationship between having a family history of breast cancer in first-degree relatives and risk of triple-negative breast cancer, and risk of two other breast cancer subtypes defined by tumor marker expression. We evaluated data collected by the Breast Cancer Surveillance Consortium from 2,599,946 mammograms on 1,054,466 women, among whom 15% reported a first-degree family history of breast cancer. Using Cox regression in this cohort, we evaluated subtype-specific associations between family history and risk of triple-negative (N = 705), estrogen receptor-positive (ER+, N = 10,026), and hormone receptor-negative/HER2-expressing (ER-/PR-/HER2+, N = 308) breast cancer among women aged 40-84 years. First-degree family history was similarly and significantly associated with an increased risk of all the subtypes [hazard ratio (HR) = 1.73, 95% confidence interval (CI): 1.43-2.09, HR = 1.62, 95% CI: 1.54-1.70, and HR = 1.56, 95% CI: 1.15-2.13, for triple-negative, ER+, and ER-/PR-/HER2+, respectively]. Risk of all the subtypes was most pronounced among women with at least two affected first-degree relatives (versus women with no affected first-degree relatives, HR(triple-negative) = 2.66, 95% CI: 1.66-4.27, HR(ER+) = 2.05, 95% CI: 1.79-2.36, HR(ER)-(/PR)-(/HER2+) = 2.25, 95% CI: 0.99-5.08). Having a first-degree family history of breast cancer was associated with an increased risk of triple-negative breast cancer with a magnitude of association similar to that for the predominant ER+ subtype and ER-/PR-/HER2+ breast cancer.

Item Type: Article or Abstract
DOI: 10.1007/s10549-010-1148-9
PubMed ID: 20814817
NIHMSID: NIHMS262820
PMCID: PMC3059326
Grant Numbers: U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, T32 CA09168, R25-CA94880
Keywords or MeSH Headings: Adult Aged Aged, 80 and over Breast Neoplasms/genetics* Cohort Studies Family Health Female Genetic Predisposition to Disease* Humans Mammography/methods Middle Aged Proportional Hazards Models Receptor, erbB-2/biosynthesis Receptors, Estrogen/biosynthesis Receptors, Estrogen/genetics Receptors, Progesterone/biosynthesis Receptors, Progesterone/genetics Risk Tumor Markers, Biological
Depositing User: Library Staff
Date Deposited: 06 Jan 2011 19:37
Last Modified: 14 Feb 2012 14:43
URI: http://authors.fhcrc.org/id/eprint/469

Repository Administrators Only

View Item View Item